1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Risperidone |
| brand | String | Risperdal (oral), Risperdal M-Tab (ODT), Risperdal Consta (biweekly IM LAI), Perseris (monthly SC LAI), Uzedy (monthly/bimonthly SC LAI), Rykindo (biweekly IM LAI) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Neuroleptics|Neuroleptic]] • [[:Category:Atypical neuroleptics|Atypical neuroleptic (second-generation)]] • [[:Category:Benzisoxazoles|Benzisoxazole]] • [[:Category:Mood stabilizers|Mood stabilizer]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-0000001C-QINU`"', '"`UNIQ--vote-0000001D-QINU`"', '"`UNIQ--vote-0000001E-QINU`"', '"`UNIQ--vote-0000001F-QINU`"', '"`UNIQ--vote-00000020-QINU`"' |
| starting_dose | String | Schizophrenia / mania: 1 mg PO BID, titrate to 4-8 mg/day. Pediatric autism irritability: 0.25-0.5 mg/day, weight-titrated. Consta LAI: 25 mg IM every 2 weeks after oral overlap |
| preparations | String | Tablets 0.25, 0.5, 1, 2, 3, 4 mg; M-Tab ODT 0.5, 1, 2, 3, 4 mg; oral solution 1 mg/mL; Consta LAI 12.5, 25, 37.5, 50 mg; Perseris SC LAI 90, 120 mg monthly |
| fda_max | String | 16 mg/day (schizophrenia, adult); 6 mg/day (bipolar maintenance, autism irritability) |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • intramuscular (LAI) • subcutaneous (LAI) |
| onset | String | Neuroleptic effect emerges over days to weeks |
| duration | String | 24 hours (oral); 2-4 weeks (LAI formulations) |
| halflife | String | Risperidone 3-20 hours; '''9-hydroxy-risperidone (paliperidone) ~20-24 hours''' is the major active metabolite and is separately marketed as a parent compound (Invega)'"`UNIQ--ref-00000021-QINU`"' |
| bioavailability | String | ~70% (oral)'"`UNIQ--ref-00000022-QINU`"' |
| pregnancy | String | Signal for neonatal extrapyramidal symptoms and withdrawal with third-trimester exposure.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US. Carries the atypical-neuroleptic '''Boxed Warning''' for increased mortality in elderly patients with dementia-related psychosis'"`UNIQ--ref-00000023-QINU`"' |
